Patents by Inventor Michael Finizio

Michael Finizio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4548943
    Abstract: Antiinflammatory, analgesic and prostaglandin synthetase inhibitory arylmethylene- and arylmethylindenoimidazoles useful for the treatment of pain, inflammation, and primary dysmenorrhea having the structure ##STR1##
    Type: Grant
    Filed: May 11, 1984
    Date of Patent: October 22, 1985
    Assignee: E. I. Du Pont de Nemours and Company
    Inventor: Michael Finizio
  • Patent number: 4548946
    Abstract: 1,8-Dihydro(or 3,8-dihydro)-8-aryl-2-[(substituted)thio]indeno[1,2-d]imidazoles and their corresponding sulfoxides and sulfones, such as 1,8-dihydro(or 3,8-dihydro)-8-phenyl-2-[(1,1,2,2-tetrafluoroethyl)sulfonyl]indeno[1,2-d]i midazole, are useful in the treatment of inflammation and/or pain.
    Type: Grant
    Filed: February 22, 1982
    Date of Patent: October 22, 1985
    Assignee: E. I. Du Pont de Nemours and Company
    Inventor: Michael Finizio
  • Patent number: 4371541
    Abstract: 3,4-Dihydro(or 1,4-dihydro)-4-aryl-2-[(substituted)thio]-[1]benzopyrano[3,4-d]imidazoles and their corresponding sulfoxides and sulfones, such as 3,4-dihydro(or 1,4-dihydro)-4-phenyl-2-[(1,1,2,2-tetrafluoroethyl)sulfonyl]-[1]benzopyran o[3,4-d]imidazole, are useful in the treatment of inflammation and/or pain.
    Type: Grant
    Filed: January 7, 1982
    Date of Patent: February 1, 1983
    Assignee: E. I. Du Pont de Nemours and Company
    Inventor: Michael Finizio
  • Patent number: 4305954
    Abstract: 3,4-Dihydro(or 1,4-dihydro)-2-[(substituted)thio]-[1]benzopyrano[3,4-d]imidazoles and their corresponding sulfoxides and sulfones, such as 7,8-dichloro-3,4-dihydro(or 1,4-dihydro)-2-[(1,1,2,2-tetrafluoroethyl)sulfonyl]-[1]benzopyrano[3,4-d]i midazole, are useful in the treatment of inflammation.
    Type: Grant
    Filed: February 11, 1981
    Date of Patent: December 15, 1981
    Assignee: E. I. Du Pont de Nemours and Company
    Inventor: Michael Finizio
  • Patent number: 4267185
    Abstract: The pyrrolylpiperidines, 1-methyl-4-(1-methylpyrrol-2-yl)-4-piperidinol, 1,2,3,6-tetrahydro-1-methyl-4-(1-methylpyrrol-2-yl)pyridine, and pharmaceutically acceptable salts thereof are useful as antidepressant agents.
    Type: Grant
    Filed: April 9, 1980
    Date of Patent: May 12, 1981
    Assignee: E. I. Du Pont de Nemours and Company
    Inventor: Michael Finizio
  • Patent number: 4065453
    Abstract: The levorotatory enantiomer of molindone [3-ethyl-6,7-dihydro-2-methyl-5-(morpholinomethyl)-indol-4(5H)-one] has been isolated and found to have significantly greater antidepressant activity than the corresponding racemate.
    Type: Grant
    Filed: November 1, 1976
    Date of Patent: December 27, 1977
    Assignee: Endo Laboratories, Inc.
    Inventor: Michael Finizio
  • Patent number: 3959300
    Abstract: Certain novel 1,2,3,4,8,9-hexahydro-3-(substituted)pyrido[4',3':2,3]indolo[1,7-ab][1]-be nzazepines are useful as minor tranquilizers (anxiolytics) and/or major tranquilizers (antipsychotics). The minor tranquilizers are effective at non-ataxic doses, and are not likely to cause addiction when abused. A representative compound in this class is 3-(cyclopropylmethyl)-1,2,3,4,8,9-hexahydropyrido[4',3':2,3]indolo[1,7-ab] [1]benzazepine.
    Type: Grant
    Filed: June 14, 1974
    Date of Patent: May 25, 1976
    Assignee: Endo Laboratories, Inc.
    Inventor: Michael Finizio
  • Patent number: D760554
    Type: Grant
    Filed: September 26, 2014
    Date of Patent: July 5, 2016
    Inventor: Michael Finizio